CCRM’s Board of Directors represents extensive experience in company creation, international academic excellence and seasoned leaders sourced from the regenerative medicine industry.

Chair

• Gregory Bonfiglio, Proteus Venture Partners, USA

Board

• Melissa Carpenter, Carpenter Group, Stem Cell Strategies, USA

• Allen Eaves, Stemcell Technologies, Inc., Canada
• Rafi Hofstein, MaRS Innovation, Canada
• Peter Lewis, University of Toronto, Canada
• Michael May, Centre for Commercialization of Regenerative Medicine, Canada
• Geoff MacKay, Organogenesis, USA
• Ruth McKernan, Pfizer Regenerative Medicine, USA and UK
• Stephen Minger, GE Healthcare, UK
• Lita Nelsen, Massachusetts Institute of Technology, USA
• Christopher Paige, University Health Network, Canada
• Duncan Stewart, Ottawa Hospital Research Institute, Canada
• Peter Zandstra, Centre for Commercialization of Regenerative Medicine, Canada